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Abst rac t
Introduction: Much less is known about grass-pollen allergens to dogs, when compared with humans. Genetic-
based patterns might play an important role in sensitization profiles, conditioning the success of allergen-specific 
immunotherapy. 
Aim: Mapping of Dactylis glomerata (D. glomerata) and Phleum pratense (P. pratense) allergens for grass pollen-
sensitized atopic dogs, for better understanding how individual allergograms may influence the response to grass-
pollen immunotherapy. 
Material and methods: To identify D. glomerata and P. pratense allergoms for dogs, 15 individuals allergic to grass 
pollen and sensitized to D. glomerata and P. pratense were selected. D. glomerata and P. pratense proteomes were 
separated by isoelectric focusing (IEF), one-dimensional (1-D) and two-dimensional (2-D) sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE). Separated proteins were blotted onto Polyvinylidene difluoride 
(PVDF) membranes and allergens were identified by patient sera IgE in Western Blotting (WB). 
Results: In D. glomerata, 17 allergens were identified from IEF and 11 from 1-D SDS-PAGE, while from P. pratense,  
18 and 6 allergens were identified, respectively. From 2-D SDS-PAGE 13 spots were identified from D. glomerata and 
27 from P. pratense. 
Conclusions: Several similarities were found between dog and human D. glomerata and P. pratense sensitization 
profiles but no relationship between clinical signs and a specific pattern of allergen recognition was observed. 
Similarities were found in each patient pattern of sensitization between D. glomerata and P. pratense, also suggest-
ing cross-reactive phenomena. Further molecular epidemiology approach is needed to understand the role of the 
sensitization pattern in allergen-specific immunotherapy effectiveness in grass-pollen allergic dogs.
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Introduction
After a clinical diagnosis of atopy, which criteria have 
been successively improved [1], extensive laboratory data 
are very useful to understand sensitization patterns and 
for a better clinical follow-up [2]. Intradermal skin test-
ing (IDT) and specific IgE determinations are also useful 
to establish eviction measures and consider allergen-
specific immunotherapy (ASIT), in order to obtain clinical 
improvement [3]. In fact, allergen-specific immunothera-
py, especially for aeroallergens, has proven to be useful 
for allergy control, by promoting substantial clinical im-
provement in 65–75% of the cases [4] and should be pre-
scribed as directed as possible [3, 5]. Nevertheless, those 
figures may be safely improved by using more specific al-
lergen pools for specific immunotherapy, which is already 
being studied for human allergy management [6–10]. 
Studies performed by Kubota et al. [11] with Cryp-
tomeria japonica pollen allergens, using sera from sen-
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sitized dogs with atopic dermatitis, showed important 
differences in terms of individual allergen recognition 
between humans and dogs. In fact, a molecule that has 
shown to be a major allergen for humans may be a minor 
one for dogs and vice versa. Sometimes, an allergen for 
a given species may even not be so for another. More re-
cently, Ognjenovic et al. [12] reported several similarities, 
as well as differences, between dog and human sensi-
tization to the Ambrosia artemisiifolia pollen, with 81% 
recognition of the 38 kDa band, belonging to the Amb a 1 
group, between sensitized dogs. 
For a precise allergy diagnosis, or indication of aller-
gen-directed eviction measures [2], as well as to improve 
the efficacy of allergen-specific immunotherapy [13], fur-
ther fine tune laboratory information on the molecular 
diagnosis seems to be truly helpful.
Following very useful concepts, such as component-
resolved diagnosis and immunotherapy (CRD and CRIT) 
[14–16], characterization of patient serum IgE spectro-
types (individual allergograms) by WB techniques, with 
electrophoretic-separated molecular allergens, may pro-
vide relevant information, especially for an immunother-
apy decision [13].
For the determination of dog-specific serum IgE, 
ELISA has been the routine laboratory method, but when 
comparing with the latest-generation methods, sensitiv-
ity and specificity has shown to be lower [17]. However, 
the lack of standardization of those new methods for 
veterinary proposal is still an obstacle. An extraordinary 
advance for allergy complementary diagnosis is based 
on the protein microarray systems [15]. The Immune 
Solid-phase Allergen Chip method (ISAC – Thermo Fisher 
Scientific, USA), despite its solely qualitative and semi-
quantitative ability, allows the detection of very small 
amounts of specific IgE, which may nevertheless be of 
clinical significance [8]. While protein microarray systems 
are still far from veterinary routine, the characterization 
of patient IgE sensitization profile by WB over electro-
phoretic-separated allergens may provide relevant infor-
mation, especially to understand particular conditions re-
lated to cross-reaction phenomena and immunotherapy 
effectiveness [2, 8, 13]. 
In this work the authors intended to further map 
Dactylis glomerata (D. glomerata) and Phleum pratense 
(P. pratense), two well-known allergen sources for hu-
mans [18, 19], allergens for grass pollen-sensitized atopic 
dogs, in order to settle the necessary conditions to start 
understanding how individual allergograms may influ-
ence the response to ASIT. 
Aim
By mapping D. glomerata and P. pratense allergens for 
grass pollen-sensitized atopic dogs, the authors intended 
to disclose the allergens from those two relevant sources 
for dogs, for further understanding how individual aller-
gograms may influence the response to grass-pollen im-
munotherapy. 
Material and methods
Patient selection and characterization
At the dermatology and allergy outpatient consul-
tation from the University of Évora Veterinary Hospital 
(Évora, Portugal), all the patients were submitted to an 
extensive query for anamnestic and clinical parameters 
and selected by filling the clinical criteria defined by the 
International Task Force on Canine Atopic Dermatitis for 
atopy diagnosis [1]. For further selection, patients were 
submitted to IDT with different allergen sources, such as 
grass, herbs and tree pollens, mites and fungi, and posi-
tive (histamine solution) and negative (solvent extract) 
controls from Bial Aristegui (Bilbao, Spain). Specific IgE 
for a panel of the most common mites and pollens was 
also determined according to Lee et al. [20] (Univet, Bar-
celona, Spain). Fourteen of those, mostly indoor patients 
and presenting atopic dermatitis, which tested positive in 
the IDT and presented with specific IgE for D. glomerata 
and P. pratense, were selected. Only one patient (no. 6) 
was already undergoing specific immunotherapy. 
Allergen extract preparation
Lyophilized pollens from D. glomerata and P. pratense 
(Allergon, Angelholm, Sweden) were submitted to extrac-
tion by 2 h orbital stirring at 1 : 10 in 4oC double-distilled 
water, for IEF, and in phosphate buffered saline (PBS) 
for SDS-PAGE. The extract was centrifuged at 3500 g for 
10 min at 4°C and supernatant protein concentration 
measured according to the Warburg Christian Method 
[21] in a spectrophotometer (Beckman DU530 UV-VIS, 
Beckman Coulter, Brea, USA). 
Protein separation
Isoelectric focusing (IEF)
Dactylis glomerata and P. pratense extracts (protein 
concentration of 4.6 mg/ml) were subjected to pH 3–10 
IEF (Ampholytes from GE Healthcare, USA) in 5% poly-
acrylamide gel (Acrylamide/Bisacrylamide from Bio-Rad, 
Hercules, USA). Separated proteins were then blotted 
onto methanol-activated 0.2-µm-pore PVDF membranes 
(Bio-Rad) according to the technique described by Mar-
tins et al. [22] for isoelectric-focused protein transference. 
Both extracts were also subjected to IEF, to produce 1-D 
gel strips for the 2-D gel electrophoresis.
SDS-PAGE
Dactylis glomerata and P. pratense extracts were 
treated with SDS, under non-reducing conditions, and 
submitted to 12% PAGE. Separated proteins were blot-
ted under electrotransference [23] onto 0.2 µm-pore 
PVDF membranes in a Trans-Blot Semi-Dry Transfer Cell 
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(Bio-Rad). Two-dimensional separations were performed 
by 12% SDS-PAGE of the 1-D IEF strips and separated pro-
teins were also blotted onto methanol-activated 0.2 µm-
pore PVDF membranes. 
Antigen detection – immunoblotting
One-dimensional blotted membranes were cut in 
3-mm-wide strips and immersed for 2 × 0.5 h in block-
ing buffer (1% non-fat dry milk – 0.1% Tween-20 in Tris-
buffered saline, at pH 7.4) at room temperature and each 
strip was incubated overnight with individual patient 
sera, diluted at 1 : 10 in 1 ml blocking buffer. Fourteen 
patients’ (no. 1 to 14) sera were tested with D. glomerata 
and P. pratense strips, from IEF and from SDS-PAGE. Two 
samples were used from patient no. 6: one before immu-
notherapy (6B) and another after a year of immunother-
apy (6A). For specific IgE detection, strips were incubated 
for 2 h with horseradish peroxidase-conjugated goat 
anti-dog-IgE antibody (Bethyl Laboratories, Inc., Mont-
gomery, USA) at 1 : 1000 in blocking buffer, followed by 
4 × 5 min washes in 0.9% NaCl – 0.1% Tween-20. Another 
4 × 5 min washing cycle was carried out and specific IgE 
visualization performed by chromogenic reaction with 
3.3’-diaminobenzidine/NiCl2 (Sigma-Aldrich, St. Louis, 
USA) in Tris-buffered saline at pH 7.4.
Two-dimensional immunoblottings were performed 
by incubating blotted membranes with a pool of 7-pa-
tient sera (no. 1, 2, 3, 5, 6A, 13 and 14), selected for their 
representative IgE binding in IEF and 1-D SDS-PAGE 
blots, diluted to 1 : 10 in 18 ml blocking buffer. Specific 
IgE was detected by anti-dog-IgE biotin-labeled mono-
clonal antibody (AbD Serotec, Kidlington, UK) at 1 : 500 
in blocking buffer, followed by 4 × 5 min washes in 0.9% 
NaCl – 0.1% Tween-20 and 1 h incubation with ExtrAvidin-
alkaline phosphatase (Sigma-Aldrich) at 1 : 5000. Another 
4 × 5 min washing cycle was done and specific IgE vi-
sualization was performed by chromogenic reaction 
with nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl 
phosphate (Sigma-Aldrich) in substrate buffer. Controls 
(B – blank) were performed with sera from 4 non-atopic 
dogs, negative for specific IgE to grass pollens.
Statistical analysis
Data distribution was verified with the Kolmogorov-
Smirnov test and homogeneity of variance assessed by 
the Levene’s test. As there was no normal distribution, 
the correlation between two variables was determined 
by the Spearman’s rank correlation coefficient, consider-
ing p < 0.05 as significant.
Results
All patients presented with specific IgE and positive 
IDT for D. glomerata and/or P. pratense. Mean specific IgE 
was 753.0 Elisa absorbance units (EAU) to D. glomerata 
(min. of 92 and max. of 3204) with a standard devia-
tion (SD) of 738.4, and 874.8 EAU to P. pratense (min. of 
89 and max. of 3426; SD = 894.0).
From D. glomerata IEF separation, at least 17 allergens 
were identified from pI 3.7 to 9.1 (Figure 1 and Table 1). 
From these 17, 10 bands (pI 3.9, 4, 4.2, 4.3, 4.4, 4.8, 5.4, 
7.6, 7.7 and 9.1) showed major recognition (Table 1 and 
Figure 1). The mean number of D. glomerata recognized 
IEF allergen bands/patient was 9.2 (min. of 3 and max. of 
15; SD = 3.38). Two allergen bands (pI 5.4 and 7.6) were 
recognized by more than 85% of the patients and anoth-
er one (pI 4.8) was recognized by all patients, while two 
others (pI 3.7 and 6.5) were only recognized by one pa-
tient, each (no. 9 and no. 8, respectively). From P. pratense 
IEF separation, at least 18 allergens were identified from 
pI 4 to 9.8. From these 18, seven bands showed major 
recognition (pI 4, 4.5, 4.8, 4.9, 5.4, 8.1 and 9.8), while 
three bands (pI 7.3, 7.6 and 9.4) were only recognized by 
one patient (no. 3) and patient no. 9 only recognized two 
allergens (pI 4 and 6.1) (Table 2 and Figure 1). The mean 
number of P. pratense recognized IEF allergen bands/pa-
tient was 6.9 (min. of 2 and max. of 17; SD = 4.15). 
From D. glomerata 1-D SDS-PAGE, 12 allergens were 
identified by patient sera, with molecular weights (MW) 
from 11 to 110 kDa. Seven of these allergen bands (MW 
close to 16, 23, 27, 35, 42, 45 and 65 kDa) showed ma-
jor recognition. The mean number of D. glomerata rec-
ognized PAGE allergen bands/patient was 6.9 (min. of 
4 and max. of 8; SD = 1.09). Six allergen bands (16, 27, 
35, 42, 45, 65 kDa) were recognized by more than 85% 
of the patients and two bands (MW close to 43.5 and 
110 kDa) were only recognized by one patient (no. 12). From 
P. pratense 1-D SDS-PAGE, eight allergen bands were 
recognized from 11 to 136 kDa and the mean number of 
recognized PAGE allergen bands/patient was 4.4 (min. of 
Figure 1. IgE immunoblots from D. glomerata and P. pratense 
IEF, revealed with horseradish peroxidase-conjugated goat 
anti-dog-IgE. Patients/lanes no. 1–14. Patient no. 6 before 
(6B) and after (6A) specific immunotherapy B – Blank con-
trols without serum
Dac gpH Phl p
9.3 9.3
8.65 8.65
8.45 8.45
8.15 8.15
7.35 7.35
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6.55 6.55
5.85 5.85
5.2 5.2
4.55 4.55
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1 and max. of 6; SD = 1.28). Three allergen bands (MW 
close to 27, 35 and 42 kDa) showed major recognition, 
with the 27 kDa band being recognized by all the pa-
tients. 
Patient no. 6, who had undergone 1-year ASIT, with 
a significant clinical improvement, changed his pattern of 
recognition towards the D. glomerata allergom (Tables 1 
and 3), by failing to recognize the pI 8.7 (Figure 1) and the 
47 kDa (Figure 2) bands and beginning to recognize the pI 
5 band (Figure 1). Patient no. 6 also changed his pattern 
of recognition regarding P. pratense (Tables 2 and 4), by 
failing to recognize the pI 9.5 and 9.8 (Figure 1) and the 
11 kDa (Figure 2) bands, and beginning to recognize the 
pI 4.9 and 5.4 bands (Figure 1). 
Table 2. Allergens recognized from P. pratense IEF
Patients Phleum pratense allergens (estimated pI*)
4 4.5 4.6 4.8 4.9 5.1 5.4 5.6 6.1 7.1 7.3 7.6 8.1 8.8 9 9.4 9.5 9.8
1 x x x x x x x x x x x x
2 x x x x
3 x x x x x x x x x x x x x x x x x
4 x x x x x
5 x x x x
6B x x x x
6A x x x x
7 x x x x x x x x x
8 x x x x x
9 x x
11 x x x x x x x
13 x x x x x x x x x x
14 x x  x x  x      x     x
*Isoelectric point.
Table 1. Allergens recognized from D. glomerata IEF
Patients Dactylis glomerata allergens (estimated pI*)
3.7 3.9 4 4.2 4.3 4.4 4.8 5 5.4 5.7 6.5 6.8 7.6 7.7 8.3 8.7 9.1
1 x x x x x x x x x x x
2 x x x x x x x
3 x x x x x x x x x x x x x x x
4 x x x x x x x x x x x x x x
5 x x x x x x x x
6B x x x x x x x x x x
6A x x x x x x x x x x
7 x x x x x x x x
8 x x x x x x
9 x x x x
10 x x x
11 x x x x x x x x x
12 x x x x x x x x x x x x
13 x x x x x x x x x
14  x x x x x x x x    x x x  x
*Isoelectric point.
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Two dimensional separation from D. glomerata dis-
closed 13 allergenic spots, from pI < 3.85 to > 7.9 and 
from 7 to 112 kDa (Figure 3), while to P. pratense, 27 al-
lergenic spots were disclosed from pI < 3.85 to > 9.7 and 
from 9 to 85 kDa (Figure 4).
In a range from 1 to 4, the mean IDT score to D. glom-
erata was 2.3 (min. of 2 and max. of 4; SD = 0.602). To 
P. pratense, the mean IDT score was 2.0 (min. of 1 and 
max. of 3; SD = 0.516).
A significant positive correlation (r = 0.902) was 
verified between specific IgE to D. glomerata and the 
respective IDT scores, with a marked variability in indi-
vidual specific IgE levels (SD = 738.4). A moderate posi-
tive correlation (r = 0.422) was found between specific 
IgE to P. pratense and the respective IDT scores, also 
with a marked variability in individual specific IgE lev-
els (SD = 894.0). A significant positive correlation was 
verified between specific IgE, either to D. glomerata or to 
P. pratense, and their respective number of recognized 
IEF allergens (r = 0.570 and r = 0.710). A significant posi-
tive correlation was also found between IDT scores to 
D. glomerata and to P. pratense, and to their respec-
tive number of recognized IEF allergens (r = 0.649 and 
r = 0.660). No significant correlation was verified be-
tween IDT scores to D. glomerata and to P. pratense, and 
their respective number of recognized PAGE allergens 
(r = –0.070 and r = –0.216). No significant correlation was 
also verified between specific IgE to D. glomerata or to 
P. pratense and the number of their recognized PAGE al-
lergens (r = 0.009 and r = –0.036, respectively).
A significant positive correlation was found be-
tween specific IgE levels to D. glomerata and P. pratense 
(r = 0.706), and between the number of D. glomerata and P. 
pratense recognized IEF allergens (r = 0.604). Between the 
number of D. glomerata and P. pratense recognized PAGE al-
lergens, no significant correlation was observed (r = 0.152), 
whereas between IDT scores to both species, a moderate 
positive correlation was observed (r = 0.428). Besides, 
there was no significant correlation between the number 
Figure 2. IgE immunoblots from D. glomerata and P. pratense 
SDS-PAGE, revealed with horseradish peroxidase-conju-
gated goat anti-dog-IgE. Patients/lanes no. 1–15. Patient 
no. 6 before (6B) and after (6A) specific immunotherapy. 
B – Blank controls without serum. Note: no lane from pa-
tient no. 15 in the D. glomerata set and no lanes from pa-
tients no. 10 and 12 in the P. pratense set
Table 3. Allergens recognized from D. glomerata SDS-
PAGE 1-D
Patients Dactylis glomerata allergens (estimated MW* [kDa])
11 16 23 27 32 35 42 43,5 45 47 65 110
1 x x x x
2 x x x x x x x
3 x x x x x x x x
4 x x x x x x
5 x x x x x x
6B x x x x x x x x
6A x x x x x x x
7 x x x x x x x
8 x x x x x x
9 x x x x x x x
10 x x x x x x x
11 x x x x x x x x
12 x x x x x x x x
13 x x x x x x x x
14 x x x x x x
*Molecular weight.
Table 4. Allergens recognized from P. pratense SDS-PAGE 1-D
Patients Phleum pratense allergens (estimated MW* [kDa])
11 16 27 35 42 47 55 136
1 x x x x
2 x x x x
3 x x x x x
4 x x x x x
5 x x x
6B x x x x x x
6A x x x x x
7 x x x x x
8 x x x x x
9 x
11 x x x x x
13 x x x x
14 x x x x
15 x  x x x x x  
*Molecular weight.
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of recognized allergens from IEF and from PAGE, by each 
patient, in either D. glomerata or P. pratense. Although, 
a tendency to recognize a higher number of IEF allergens, 
when compared to PAGE allergens, was individually seen. 
Two-dimensional separation disclosed multiple al-
lergen spots from D. glomerata and P. pratense. Four-
teen spots (a to n) were identified from D. glomerata (pI 
3.8 to 7.9 and MW 7 to 75 kDa) (Figures 3 A and B) and 
33 (a to z7) from P. pratense (pI < 3.5 to 9.1 and MW 8 to 
83 kDa) (Figures 4 A and B). Diagrams from Figures 3 B 
and 4 B show clearer representations of D. glomerata and 
P. pratense 2-D allergoms. Controls with the non-atopic 
dogs, negative for specific IgE to grass pollens, showed 
no recognition in WB.
Discussion 
No clear clinical differences were possible to identify 
among patients. Hence, no specific IgE level, IDT score or 
pattern of spectrotype was possible to relate to a specific 
clinical pattern. Similarly to house-dust mite allergy [24], 
IDT scoring seemed to be a reliable parameter in terms 
of correspondence to the level of specific IgE to D. glom-
erata and P. pratense. However, such high correlation may 
Figure 3. A – IgE immunoblot from D. glomerata 2-D separation, revealed with biotin-ExtrAvidin-alkaline phosphatase 
anti-dog-IgE. Dog D. glomerata allergogram with a pool of sera. B – Two-dimensional diagram from dog D. glomerata al-
lergogram in Figure 3 A. Recognized allergen spots are identified from a to n
A B
Figure 4. A – IgE immunoblot from P. pratense 2-D separation, revealed with biotin-ExtrAvidin-alkaline phosphatase anti-
dog-IgE. Dog P. pratense allergogram with a pool of sera. B – Two-dimensional diagram from dog P. pratense allergogram 
in Figure 4 A. Recognized allergen spots are identified from a to z7
A B
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not occur between specific IgE levels or IDT scores and 
the number of recognized allergens from PAGE.
From the individual allergograms observed among 
this clinically homogeneous group of patients, sensiti-
zation profiles were found to be rather diverse. In fact, 
a great diversity of individual spectrotype patterns was 
revealed – patient no. 9 recognized only 1 allergen band 
from P. pratense PAGE, while others, such as patients 
no. 6 and 14, recognized up to 6 bands. From P. pratense 
IEF, patient no. 9 recognized only 2 bands, while patient 
no. 3 recognized 17. The same trend was registered with 
regard to D. glomerata PAGE, where patient no. 1 recog-
nized just 4 allergen bands, while patients no. 3, 6, 11, 12 
and 13 recognized up to 8 bands. From D. glomerata IEF, 
the number of bands recognized ranged from 3 (patient 
no. 10) to 15 (patient no. 3). The number of recognized 
IEF-separated allergens was definitely lower in individual 
dogs than in humans, where more than 30 bands were 
individually recognized [25].
Dog patients with higher specific IgE levels also 
showed a higher allergen recognition signal in WB, as 
described for humans by Peltre et al. [18, 25], using the 
radioactive protocol for IgE detection. 
As observed with humans [26], a wide range of iden-
tified D. glomerata and P. pratense allergens was dis-
closed for dogs and several similarities were also found 
between dog and human D. glomerata and P. pratense 
sensitization profiles. The pI range of the identified D. 
glomerata allergens for dogs (pI 3.7–9.1) was similar to 
the humans’ (pI 4.1–10.5) and the P. pratense pI range of 
identified allergens for dogs (pI 4–9.8) was even closer to 
the human’s range (pI 4.2–9.5). Towards D. glomerata an 
allergen band with pI 5.9, probably Dac g 1, was the most 
recognized by humans [19], whereas in dogs the closest 
pI of a recognized allergen band was 5.7 and it was only 
recognized by 2 patients (no. 3 and 4). Although regarding 
P. pratense, 2 allergen bands (pI 4.9 and 5.4), which may 
correspond to Phl p 5 (pI 4.2–7.5), a highly recognized al-
lergen by humans [19], also showed highly recognition by 
individual dogs (10 out of 12 dogs).
Some similarities were also found between dog and 
human sensitization profiles, regarding PAGE-separated 
D. glomerata and P. pratense allergens. The 27 kDa and 
the 11 kDa D. glomerata allergens, probably correspond-
ing, to Dac g 5 and Dac g 2, respectively, two major aller-
gens for humans, were also identified by dogs, but only 
the 27 kDa band presented major recognition by dogs 
(12 out of 14 dogs). The 27 kDa and the 11 kDa P. pratense 
allergen bands, probably corresponding to Phl p 5 and 
Phl p 2, respectively, were also recognized by dogs and 
the 27 kDa band was even recognized by all of the sen-
sitized dogs. Yet, regardless of the highly cross-reactive 
condition observed between different grass pollen spe-
cies in humans that was not quite demonstrated among 
dogs. In fact, considerable differences were found be-
tween each patient Dactylis glomerata and Phleum 
pratense allergograms in the study population, as it was 
also reported with regard to Cryptomeria japonica [11] 
and Ambrosia artemisiifolia [12].
As in humans [26], mean specific IgE, either to 
D. glomerata or P. pratense, also presented a very high 
variability, with no correspondence to the severity of 
clinical signs. Nevertheless, a significant positive corre-
lation was found between specific IgE and IDT scores, 
especially regarding D. glomerata, which may be under-
standable since the cutaneous reaction upon intradermal 
inoculation of the allergen extract seems to depend on 
the level of existent specific IgE. However, no correspon-
dence was verified between IDT scores and the severity 
of the clinical signs. The relevant positive correlation veri-
fied between the level of specific IgE to D. glomerata and 
P. pratense, and the respective number of recognized IEF 
allergens, but not with regard to PAGE allergens, could 
be associated with a more conformational condition of 
humoral epitopes, which may be further preserved by 
the IEF, as a native method. Observing the correlations, 
early verified between IDT and specific IgE, and between 
specific IgE and the number of IEF-separated allergens, 
a significant positive correlation between the IDT scores 
to D. glomerata and the number of D. glomerata IEF-sep-
arated allergens was expected, by the same reasoning. 
Although, such conditions were not verified with respect 
to the number of PAGE allergens, either from D. glom-
erata or P. pratense, where no significant correlation was 
found with the respective levels of specific IgE and IDT 
scores. No relevant correlation was also found between 
the number of D. glomerata or P. pratense IEF and PAGE-
separated allergens. 
Individual spectrotypes, mainly 2-D allergograms, has 
already shown great utility for the identification of the 
implicated allergen molecules in human latex allergy, 
as demonstrated by Chardin and Peltre [2]. The inter-
pretation of molecular allergen recognition may also be 
of great importance for an efficient immunotherapy ap-
proach, since the use of rather specific molecular aller-
gens, instead of traditional commercial extracts, resulted 
in an additional 60% improvement following immuno-
therapy in humans [13], and it is honest to predict the 
same trend in dog. Therefore, previous knowledge of the 
individual sensitization allergograms should play a key 
role for more efficient allergen-directed immunotherapy 
in dog. Improvement in immunotherapy effectiveness 
may also be expected in dogs by the use of individual-
specific vaccines with molecular allergens. 
The usefulness of molecular epidemiology had also 
been defined by Bessot and Pauli [6], concerning mite 
allergy in humans, because it would lead to a better un-
derstanding of the cross-reaction phenomena between 
different mite species, either from the same family or not. 
Further knowledge on this subject will probably open new 
prospects for a more specific immunotherapy, based on 
genetically hypoallergenic variants of major allergens [6].
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In our study, after a 1-year course of specific im-
munotherapy, patient no. 6 showed a remarkable clini-
cal improvement, with a change in D. glomerata and 
P. pratense spectrotype complexity, which could be asso-
ciated with several Th2-like immunological mechanisms, 
occurred in the initial phase of immunotherapy [27–29], 
and suggesting a lack of absolute correlation between 
sensitization and allergy. Such observations were also 
made by Martins et al. [24], with an allergic patient, re-
garding Dermatophagoides pteronyssinus mite spectro-
types, but so far it has not been possible to detect any 
correlation between that and the efficacy of immuno-
therapy. More patients should be studied to confirm any 
possible early/late evolution in sensitization during the 
course of specific immunotherapy. However, until a more 
“tailor-made” immunotherapy becomes available, based 
on a true component-resolved molecular diagnosis [15, 
16], extract mixes for immunotherapy are certainly use-
ful, because species such as grass pollens are widely 
spread throughout the world, and thus, those mixtures 
undoubtedly tend to reproduce the natural exposure en-
vironment, frequently with a beneficial clinical effect [9]. 
Nevertheless, immunotherapy may be safely improved by 
using more accurate allergen pools for specific immuno-
therapy, which is already being studied for human allergy 
management [6–10].
As a future trend we think that the concept of CRD 
[15] and consequent CRIT [16] may also be applied to 
veterinary allergology. A possible example of those con-
cepts could be applied towards the rather dog-recognized 
band of 27 kDa, either from D. glomerata or P. pratense, 
which may correspond to group 5 of grass pollen aller-
gens. Hence, future experiments should investigate the 
precise molecular weight mass and amino-acid sequence 
of those molecules, by matrix-assisted laser desorption/
ionization time-of-flight/time-of-flight (MALDI-TOF/TOF) 
Mass spectrometry (MS), as demonstrated by Leung and 
Pitts [30]. Additionally, the use of rather specific identify-
ing antibodies in WB or WB inhibition, by previous incu-
bation of patient sera with selected natural or recombi-
nant allergen molecules, may also allow direct or indirect 
2D molecular spot identification. In fact, CRD is already 
being applied to human allergy management, through 
the Immune Solid-phase Allergen Chip (ISAC – Thermo 
Fisher Scientific, USA) diagnostic resource. However, while 
this trademark method is still not available for veterinary 
purposes, we consider that the identification and char-
acterization of the most relevant allergens, especially for 
dogs, should continue through other available methods. 
For a better characterization of these identified allergens, 
further studies using several allergen-specific antibod-
ies, recombinant allergens and mass spectrometry tech-
niques are presently in progress. Additionally, as proposed 
by Canonica et al. [31] in a consensus document for the 
World Allergy Organization, the microchip-based molecu-
lar epidemiology concept diagnosis will facilitate identify-
ing (i) genuine versus cross-reactive sensitization in poly-
sensitized patients, thereby improving the understanding 
of triggering allergens; (ii) the risk of severe systemic ver-
sus mild local reactions in food allergy, without the need 
for challenge testing with unnecessary consequences and 
(iii) patients and triggering allergens for immunotherapy.
In fact, etiological diagnosis of pollen sensitization is 
usually difficult, because of a wide variety of sensitiz-
ing pollens, which is also associated with food allergy, 
frequently configuring a poly-sensitization status, due 
to several panallergens [32]. Associated with this poly-
sensitization status in humans, a low concordance be-
tween skin-prick-tests (SPT) was observed, especially 
with regard to patients sensitized to panallergens, such 
as profilin and polcalcin. In these cases, patients pre-
sented many more positive results in SPT. Additionally, 
patients sensitized to profilin or to lipid-transfer proteins 
have been clearly associated with food allergy [32]. This 
etiopathogenic relation between food allergy and atopy 
also needs clarification for dogs and other animals. 
Evidence of an allergen epitope community within 
the Pooideae subfamily of grass pollens was also found 
for dogs, since P. pratense itself showed a large variety 
of allergens in the 2-D allergom spectrum, standing in 
agreement with Martínez-Cócera et al. [10] and Hejl 
et al. [9] observations.
Dog, as well as horse and cat allergy framework, har-
bor similar important parameters, such as IgE, IgE recep-
tor repertoire and expression pattern, and the same in-
volved cell types (mast cells, eosinophils and T-regulatory 
cells) for sensitization and for allergy diagnosis, suggest-
ing to be possible models for translational studies [33]. 
As for humans, studies of molecular epidemiology in 
dog allergy will allow clarifying the evolution of allergic 
response during immunotherapy. Further characteriza-
tion of D. glomerata and P. pratense identified allergens, 
using allergen-specific antibodies, as well as recombi-
nant allergens and mass spectrometry techniques is in 
preparation. Hence, besides the very close clinical pat-
terns between different patients, the individual pattern 
of sensitization for each allergenic source may also be-
come of an outstanding relevance to the success of a real 
allergen-specific immunotherapy.
In conclusion, no clear clinical differences were 
possible to identify from among patients. Hence, no 
specific IgE level, IDT score or pattern of sensitiza-
tion was possible to relate to a specific clinical pat-
tern. Specific IgE to D. glomerata and to P. pratense 
presented high variability, with no correspondence 
to the severity of clinical signs. Sensitization profiles 
were found to be rather diverse from patient to pa-
tient, with a lack of absolute correlation between sen-
sitization and allergy. However, patients with higher 
specific IgE levels tended to show a higher allergen 
recognition signal in WB. Several similarities were 
found in the patient pattern of sensitization between 
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D. glomerata and P. pratense, suggesting cross-reactive 
phenomena. Similarities were found between dog and 
human D. glomerata and P. pratense sensitization pro-
files. No correlation was found between specific IgE 
levels or IDT scores and the number of recognized al-
lergens from PAGE. The IDT scoring seemed to be a reli-
able parameter in terms of correspondence to the level 
of specific IgE to D. glomerata and P. pratense. Charac-
terization of a patient IgE sensitization profile by WB 
over electrophoretic-separated allergens may provide 
relevant information, especially to understand particular 
conditions related to cross-reaction phenomena and im-
munotherapy effectiveness. Further molecular epidemi-
ology approach is needed to understand the role of the 
sensitization pattern in allergen-specific immunotherapy 
effectiveness in grass-pollen allergic dogs.
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